Continuous high-titer HIV-1 vector production

被引:133
作者
Ikeda, Y
Takeuchi, Y
Martin, F
Cosset, FL
Mitrophanous, K
Collins, M
机构
[1] UCL, Windeyer Inst, Dept Immunol & Mol Pathol, London W1T 4JF, England
[2] Ecole Normale Super Lyon, F-69364 Lyon, France
[3] Oxford BioMed Ltd, Oxford, England
基金
英国医学研究理事会;
关键词
D O I
10.1038/nbt815
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human immunodeficiency virus type 1 (HIV-1)-based vectors are currently made by transient transfection, or using packaging cell lines in which expression of HIV-1 Gag and Pol proteins is induced(1-3). Continuous vector production by cells in which HIV-1 Gag-Pol is stably expressed would allow rapid and reproducible generation of large vector batches. However, attempts to make stable HIV-1 packaging cells by transfection of plasmids encoding HIV-1 Gag-Pol have resulted in cells which secrete only low levels of p24 antigen (20-80 ng/ml)(4-6), possibly because of the cytotoxicity of HIV-1 protease(7). Infection of cells with HIV-1 can result in stable virus production(8); cell clones that produce up to 1,000 ng/ml secreted p24 antigen have been described(9). Here we report that expression of HIV-1 Gag-Pol by a murine leukemia virus (MLV) vector allows constitutive, long-term, high-level (up to 850 ng/ml p24) expression of HIV-1 Gag. Stable packaging cells were constructed using codon-optimized HIV-1 GagPol(10) and envelope proteins of gammaretroviruses; these producer cells could make up to 10(7) 293T infectious units (i.u.)/ml (20 293T i.u./cell/day) for at least three months in culture.
引用
收藏
页码:569 / 572
页数:4
相关论文
共 20 条
[1]   Restriction of lentivirus in monkeys [J].
Besnier, C ;
Takeuchi, Y ;
Towers, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11920-11925
[2]   A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-BASED RETROVIRAL VECTOR SYSTEM UTILIZING STABLE HIV-1 PACKAGING CELL-LINES [J].
CARROLL, R ;
LIN, JT ;
DACQUEL, EJ ;
MOSCA, JD ;
BURKE, DS ;
STLOUIS, DC .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6047-6051
[3]   Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line [J].
Corbeau, P ;
Kraus, G ;
WongStaal, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :14070-14075
[4]   HIGH-TITER PACKAGING CELLS PRODUCING RECOMBINANT RETROVIRUSES RESISTANT TO HUMAN SERUM [J].
COSSET, FL ;
TAKEUCHI, Y ;
BATTINI, JL ;
WEISS, RA ;
COLLINS, MKL .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7430-7436
[5]   High-level transduction and gene expression in hematopoietic repopulating cells using a human imunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter [J].
Demaison, C ;
Parsley, K ;
Brouns, G ;
Scherr, M ;
Battmer, K ;
Kinnon, C ;
Grez, M ;
Thrasher, AJ .
HUMAN GENE THERAPY, 2002, 13 (07) :803-813
[6]   Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy [J].
Hacein-Bey-Abina, S ;
Le Deist, F ;
Carlier, F ;
Bouneaud, C ;
Hue, C ;
De Villartay, JP ;
Thrasher, AJ ;
Wulffraat, N ;
Sorensen, R ;
Dupuis-Girod, S ;
Fischer, A ;
Cavazzana-Calvo, M ;
Davies, EG ;
Kuis, W ;
Lundlaan, WHK ;
Leiva, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (16) :1185-1193
[7]   PERSISTENT NONCYTOPATHIC INFECTION OF NORMAL HUMAN LYMPHOCYTES-T WITH AIDS-ASSOCIATED RETROVIRUS [J].
HOXIE, JA ;
HAGGARTY, BS ;
RACKOWSKI, JL ;
PILLSBURY, N ;
LEVY, JA .
SCIENCE, 1985, 229 (4720) :1400-1402
[8]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG PROTEINS ARE PROCESSED IN 2 CELLULAR COMPARTMENTS [J].
KAPLAN, AH ;
SWANSTROM, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) :4528-4532
[9]   Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences [J].
Kaul, M ;
Yu, H ;
Ron, Y ;
Dougherty, JP .
VIROLOGY, 1998, 249 (01) :167-174
[10]   Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein [J].
Kelly, PF ;
Vandergriff, J ;
Nathwani, A ;
Nienhuis, AW ;
Vanin, EF .
BLOOD, 2000, 96 (04) :1206-1214